FDA advisory committee cuts
This article was originally published in The Tan Sheet
Executive Summary
HHS expects to submit to OMB on May 24 recommendations on how FDA's advisory committee system can be downsized. The recommendations are being made in response to an executive order asking that each federal department and agency terminate not less than one-third of its advisory committees. Groups including NDMA and APhA have sent letters to FDA urging that the OTC Drugs Advisory Committee and other FDA advisory panels not be dismantled ("The Tan Sheet" May 3, p. 13).